Textbook Of Lung Cancer Second Edition

Textbook of Lung Cancer, 2nd edition, published in association with the European Society of Medical Oncology, is a comprehensive and multidisciplinary text, which examines all aspects of this disease, with contributions from a multinational team of authors on etiology, epidemiology, molecular biology, pathology, smoking, detection and management, clinical features, staging and prognostic factors, surgery, radiotherapy and chemotherapy. It provides essential information and guidance for specialist trainees in oncology, and for the many physicians and specialists involved in the field of lung cancer.

Global experts, in conjunction with the International Association for the Study of Lung Cancer, bring you up to date with today’s best approaches to lung cancer diagnosis, treatment, and follow-up. IASLC Thoracic Oncology, 2nd Edition, keeps you abreast of the entire scope of this fast-changing field, from epidemiology to diagnosis to treatment to advocacy. Written in a straightforward, practical style for the busy clinician, this comprehensive, multidisciplinary title is a must-have for anyone involved in the care of patients with lung cancer and other thoracic malignancies. Offers practical, relevant coverage of basic science, epidemiology, pulmonology, medical and radiation oncology, surgery, pathology, palliative care, nursing, and advocacy. Provides authoritative guidance from the IASLC – the only global organization dedicated to the study of lung cancer. Includes new content on molecular testing, immunotherapy, early detection, staging and the IASLC staging system, surgical resection for stage I and stage II lung cancer, and stem cells in lung cancer. Features a new full-color design throughout, as well as updated diagnostic algorithms.

This comprehensive and multidisciplinary text, produced in conjunction with the International Association for the Study of Lung Cancer, examines all aspects of this disease, with contributions from a multinational team of authors on epidemiology, biology, pathology, surgical, radiation and medical oncology, and health education. It will provide essential information and guidance for specialist trainees in oncology, and for the many physicians and specialists involved in the field of lung cancer.

Global experts, in conjunction with the International Association for the Study of Lung Cancer, bring you up to date with today's best approaches to lung cancer diagnosis, treatment, and follow-up. IASLC Thoracic Oncology, 2nd Edition, keeps you abreast of the entire scope of this fast-changing field, from epidemiology to diagnosis to treatment to advocacy. Written in a straightforward, practical style for the busy clinician, this comprehensive, multidisciplinary title is a must-have for anyone involved in the care of patients with lung cancer and other thoracic malignancies.

Lung cancer is primarily a disease of well-developed affluent countries. It is by far the most common cancer in men, and is poised to overtake breast cancer as the most common cancer in women. Yet, although it is common, preventable, and sometimes curable, very little information isavailable about what happens when you get it - which is when accessible information is most needed. In a clear, non-emotive style, this revised and updated new edition provides the answers to the questions patients with lung cancers or those involved with them are likely to ask. The first section describes the causes (and includes a chapter on stopping smoking), diagnosis, and progression of thedisease. There follows a section on the curative and symptomatic treatments available for the different types of lung cancer; and the third section, new for this edition, discusses the future prospects for the disease and its treatment. Also included are a glossary, a list of further reading, andan extensive list of addresses of organizations which can provide help and advice.

This is the second, completely updated edition of a comprehensive book in which many of the world’s leading lung cancer specialists discuss the recent advances in the radiation oncology of lung cancer and reflect on the latest research findings. The first three sections cover the basic science of lung cancer, clinical investigations, including histology and staging, and a wide range of fundamental treatment considerations. Current treatment strategies for small cell and non-small cell lung cancer are then explained and evaluated in detail, with due attention to novel approaches that promise further improvements in outcome. The various types of treatment-related toxicity are discussed, and quality of life studies and prognostic factors are also considered. After evaluating the latest technological and biological advances, including IMRT, IMAT, cyber knife treatment, and tomotherapy, the book concludes by thorough consideration of specific aspects of clinical research in lung cancer.

Although decades of laboratory and clinical research have led to incremental improvement in treatment outcome, lung cancer remains one of the most deadly diseases. This volume is unique in being devoted solely to the radiation oncology of lung cancer, and will be of great value to all who are involved in the diagnosis and treatment of the disease. Both non-small cell and small cell lung cancer are considered in detail. Current state-of-the-art treatment strategies and novel approaches that promise further improvements in outcome are explained and evaluated, with the aid of high-quality illustrations. Treatment-related toxicity is discussed, and further individual chapters focus on topics such as quality of life studies, prognostic factors and pitfalls in the design and analysis of clinical trials.

The second edition of Lung Cancer is a concise and timely summary of recent advances and new research in the field of lung cancer. Emphasizing biology, diagnosis, and treatment, it studies the factors influencing predisposition and the development of pre-neoplastic lesions, chemoprevention strategies, and surgical methods, as well as current and future advances in radiation therapy.